Carter BanksharesNASDAQ: CARE

The addition of Advocate Health Care to the Ambetter of Illinois provider network offers its members expanded access to the health system's high-quality healthcare CHICAGO , Oct. 30, 2024 /PRNewswire/ -- Ambetter of Illinois (Ambetter), a product offered by Centene Corporation (NYSE: CNC), and managed locally by Meridian Health Plan of Illinois, Inc. (Meridian), announced today the addition of Advocate Health Care to its network, which will further increase members' access to quality healthcare in the Chicagoland area. Ambetter members can now receive care at any of Advocate's 11 hospitals and 300 sites of care in Illinois, with 6,500 physicians, and 11,000 nurses.

While the top- and bottom-line numbers for Carter Bankshares (CARE) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Carter Bankshares, Inc. (CARE) came out with quarterly earnings of $0.23 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.20 per share a year ago.

NEW YORK , Sept. 17, 2024 /PRNewswire/ -- A survey of older adults in the United States reveals wide-ranging dissatisfaction with health care and related services that don't reflect and respond to how people want to live as they age.

Investors need to pay close attention to Carter Bankshares (CARE) stock based on the movements in the options market lately.

Market research data shows interest in additional glucose monitoring options for people with diabetes who use insulin Rutherford, NJ, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that an emerging science industry poster will be presented at the Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference to be held August 9-12, 2024 in New Orleans, LA. The Glucotrack poster will present market research data on the acceptance of the Company's Continuous Blood Glucose Monitor (CBGM) concept among people with type 1 and type 2 diabetes.

The headline numbers for Carter Bankshares (CARE) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

MARTINSVILLE, VA / ACCESSWIRE / July 25, 2024 / Carter Bankshares, Inc. (the "Company") (NASDAQ:CARE), the holding company of Carter Bank & Trust (the "Bank") today announced quarterly net income of $4.8 million, or $0.21 diluted earnings per share ("EPS"), for the second quarter of 2024 compared to net income of $5.8 million, or $0.25 diluted EPS, in the first quarter of 2024 and net income of $5.7 million, or $0.24 diluted EPS, for the second quarter of 2023. The pre-tax pre-provision income1 was $6.2 million for the second quarter of 2024, $7.2 million for the first quarter of 2024 and $6.2 million for the second quarter of 2023.

Carter Bankshares (CARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.